UBS Initiates Coverage On Shattuck Labs with Buy Rating, Announces Price Target of $17
10/12/2026
Impact: 80
Healthcare
UBS analyst Alice Nettleton has initiated coverage on Shattuck Labs (NASDAQ: STTK) with a Buy rating. The firm has set a price target of $17 for the company's stock.
AI summary, not financial advice
Share: